Ly6A/E expression was not impacted by anti-IFNγ treatment, but BST2 was significantly reduced, albeit modestly, in AT2 and CD24 + EC, the two major cell types that are targeted for infection by SARS-CoV-2 (Fig. 5C). The gene discussed is CD24; the disease is infection.